EHTH
eHealth, Inc.
There isn't enough reported data to score EHTH yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
EHTH Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| N/A | |
| N/A |
EHTH's profitability is currently stable, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like EHTH.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
EHTH PE Valuation
EHTH has no meaningful PE right now: it lost money over the past year.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
EHTH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect EHTH's earnings to grow and its profitability to improve, but its revenue to decline.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
EHTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q4 2024 | -$1.19 | +$1.18 |
| Q3 2024 | -$2.62 | +$0.78 |
| Q2 2024 | -$2.47 | +$0.97 |
| Q1 2024 | -$2.32 | +$1.59 |
| Q4 2023 | -$2.37 | +$1.99 |
| Q3 2023 | -$3.40 | +$2.89 |
| Q2 2023 | -$3.44 | +$3.37 |
| Q1 2023 | -$3.91 | +$2.11 |
EHTH has the stronger earnings trend. Trailing diluted EPS is down 150% for EHTH versus IREN down 347%.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
EHTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $21.3M | -60% |
| Q2 2026 | $33.6M | -45% |
| Q1 2026 | $88M | -22% |
| Q4 2025 | $326.2M | +3.5% |
| Q3 2025 | $53.9M | -7.8% |
| Q2 2025 | $60.8M | -7.7% |
| Q1 2025 | $113.1M | +22% |
| Q4 2024 | $315.2M | +27% |
EHTH's revenue is shrinking: $21M last quarter, down 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -218% | -141 points |
| Q2 2026 | -82% | -44 points |
| Q1 2026 | -3.3% | -7.5 points |
| Q4 2025 | 39% | +3 points |
| Q3 2025 | -77% | -3.1 points |
| Q2 2025 | -38% | +4.5 points |
| Q1 2025 | 4.2% | +24 points |
| Q4 2024 | 36% | +12 points |
EHTH's operating margin was −218% last quarter, down 141 points from the same quarter a year ago, near the bottom of its range since 2019.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over EHTH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN has the edge over EHTH on profitability, with a higher operating margin.
EHTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.3M | +$14.3M |
| Q2 2026 | -$5.4M | +$37.3M |
| Q1 2026 | $35.6M | -54% |
| Q4 2025 | -$36.1M | -$7.8M |
| Q3 2025 | -$25.5M | +$4.8M |
| Q2 2025 | -$42.8M | -$10.3M |
| Q1 2025 | $76.8M | +8.9% |
| Q4 2024 | -$28.3M | +$5.4M |
EHTH has the edge over IREN on cash flow, with more consistent year-over-year improvement.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
EHTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +353K shares |
| 1 year | +5.7% | +1.7M shares |
| 3 years | +16% | +4.5M shares |
| 5 years | +21% | +5.5M shares |
| Available history | +31% | +7.6M shares |
EHTH has the edge over IREN on shareholder dilution, with a more favorable share count trend.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
EHTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | 0.8x | Very low |
EHTH's net debt is about 1.1 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like EHTH.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
EHTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 22.2 | Oversold |
| Stochastic | 1.6 | Oversold |
EHTH's weekly RSI is 22 (oversold) and its Stochastic is 2 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
EHTH PE vs Financial Services Sector
| Metric | EHTH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
EHTH has no meaningful PE right now: it lost money over the past year.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
EHTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.58 | 24% below |
| 20 week MA | $0.99 | 56% below |
| 50 week MA | $1.79 | 75% below |
| 100 week MA | $3.78 | 88% below |
| 200 week MA | $5.21 | 92% below |
EHTH is in a downtrend: it's below all five of its weekly moving averages, and 92% below its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has the edge over EHTH on trend strength, trading above more of its moving averages.
EHTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $94.4 | $73.9 | -22% |
| 2021 | $73.9 | $26.9 | -64% |
| 2022 | $26.9 | $4.43 | -84% |
| 2023 | $4.43 | $8.72 | +97% |
| 2024 | $8.72 | $8.65 | -0.8% |
| 2025 | $8.65 | $4.12 | -52% |
| 2026 YTD | $4.12 | $0.44 | -89% |
EHTH has finished lower in five of the last six years. It's down 89% so far in 2026.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN has the edge over EHTH on returns for 2026, with the stronger performance.